1 |
|
|
Conditions: |
|
HIV-Dementia; HIV-Associated Cognitive Motor Complex; AIDS Encephalopathy; AIDS Dementia Complex; AIDS-Related Dementia Complex; HIV Infections; Healthy |
Intervention: |
|
Drug: [11C]PBR28 |
|
2 |
|
|
Conditions: |
|
HIV-1 Infections; HIV Infections |
Interventions: |
|
Drug: Tenofovir Disoproxil Fumarate (TDF); Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF); Drug: Placebo |
|
3 |
|
|
Conditions: |
|
HIV Infections; HIV-1; Human Immunodeficiency Virus Type 1 |
Interventions: |
|
Drug: TMC278; Drug: efavirenz |
|
4 |
|
|
Conditions: |
|
HIV Infections; Acquired Immunodeficiency Syndrome; Tuberculosis |
Interventions: |
|
Drug: INH, Rifampicin, Ethambutol and Pyrazinamide; Drug: INH, Rifampicin, Ethambutol and Pyrazinamide |
|
5 |
|
|
Conditions: |
|
HIV Infections; Acquired Immunodeficiency Syndrome |
Interventions: |
|
Drug: Vicriviroc maleate 30 mg; Drug: Placebo |
|
6 |
|
|
Conditions: |
|
HIV Infections; Human Immunodeficiency Virus; Acquired Immune Deficiency Syndrome |
Interventions: |
|
Biological: HIV glycoprotein 140 ZM96 (vaccine); Biological: Carbopol 974 |
|
7 |
|
|
Conditions: |
|
AIDS Vaccines; HIV Infections; HIV-1 |
Interventions: |
|
Drug: VRC-HIVADV027-00-VP; Drug: VRC-HIVADV038-00-VP |
|
8 |
|
|
Conditions: |
|
HIV Infections; Acquired Immunodeficiency Syndrome |
Intervention: |
|
Behavioral: Structured Ecosystems Therapy (SET) |
|
9 |
|
|
Condition: |
|
HIV Infections |
Interventions: |
|
Biological: pHIS-HIV-AE DNA Prime; Biological: rFPV-HIV-AE Booster; Biological: Placebo |
|
10 |
|
|
Conditions: |
|
HIV Seronegativity; HIV Infections |
Intervention: |
|
|
|
11 |
|
|
Conditions: |
|
HIV Infections; Fatigue; HIV Positive; AIDS; Healthy Volunteer; HV |
Intervention: |
|
|
|
12 |
|
|
Condition: |
|
HIV Infections |
Interventions: |
|
Biological: HIV-1 gag DNA; Biological: IL-15 DNA adjuvant; Biological: IL-12 DNA adjuvant |
|
13 |
|
|
Conditions: |
|
HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; HIV Infections; Metabolic Syndrome X; Body Weight Changes |
Interventions: |
|
Drug: Recombinant Human Growth Hormone; Drug: Rosiglitazone; Drug: Recombinant Human Growth Hormone and Rosiglitazone; Drug: Placebo human growth hormone and placebo rosiglitazone |
|
14 |
|
|
Conditions: |
|
HIV Infections; Acquired Immunodeficiency Syndrome |
Interventions: |
|
Drug: Vicriviroc; Drug: Placebo |
|
15 |
|
|
Conditions: |
|
HIV Infections; HIV-HBV Co-Infection |
Intervention: |
|
|
|
16 |
|
|
Conditions: |
|
HIV; HIV Infections |
Intervention: |
|
Drug: tenofovir |
|
17 |
|
|
Conditions: |
|
HIV Infections; HIV |
Intervention: |
|
Drug: Interleukin-2, Proleukin |
|
18 |
|
|
Condition: |
|
HIV Infections |
Interventions: |
|
Biological: pGA2/JS7 DNA; Biological: Modified vaccinia Ankara/HIV62 |
|
19 |
|
|
Condition: |
|
HIV Infections |
Intervention: |
|
Other: Observation |
|
20 |
|
|
Conditions: |
|
HIV Infections; Acquired Immunodeficiency Syndrome |
Interventions: |
|
Behavioral: Motivational interview; Behavioral: Observed therapy |
|
21 |
|
|
Conditions: |
|
HIV Infections; Cardiovascular Disease; Insulin Resistance; HIV Lipodystrophy; The Metabolic Syndrome |
Interventions: |
|
Drug: Pioglitazone; Behavioral: Exercise Training |
|
22 |
|
|
Conditions: |
|
HIV -1 Infection; HIV Infections |
Interventions: |
|
Drug: PRO 140 (humanized monoclonal antibody to CCR5); Drug: Placebo Comparator |
|
23 |
|
|
Conditions: |
|
HIV-Hepatitis co-Infection; HIV Infections |
Intervention: |
|
|
|
24 |
|
|
Condition: |
|
HIV Infections |
Interventions: |
|
Drug: Atazanavir; Drug: Didanosine; Drug: Efavirenz; Drug: Emtricitabine/Tenofovir disoproxil fumarate; Drug: Lamivudine; Drug: Lopinavir/Ritonavir; Drug: Nevirapine; Drug: Stavudine; Drug: Tenofovir disoproxil fumarate; Drug: Zidovudine/Lamivudine |
|
25 |
|
|
Conditions: |
|
HIV Infections; HIV-1 |
Interventions: |
|
Drug: TMC278; Drug: efavirenz |
|
26 |
|
|
Conditions: |
|
Primary HIV (Acute or Early); Chronic HIV Infection |
Intervention: |
|
Drug: Tenofovir disoproxil fumarate and emtricitabine (TDF/FTC; Truvada) plus the integrase inhibitor, raltegravir. |
|
27 |
|
|
Condition: |
|
HIV Infections |
Intervention: |
|
Biological: HIV gp120/NefTat/AS02A Vaccine |
|
28 |
|
|
Condition: |
|
HIV Infections |
Interventions: |
|
Behavioral: Cognitive behavioral intervention; Behavioral: Standard counseling |
|
29 |
|
|
Conditions: |
|
Substance-Related Disorders; Drug Addiction; Human Immunodeficiency Virus; AIDS; HIV Infections |
Interventions: |
|
Other: Physician Management; Behavioral: Counseling |
|
30 |
|
|
Condition: |
|
Acquired Immunodeficiency Syndrome |
Interventions: |
|
Behavioral: Couples HIV counseling and testing; Behavioral: Women's relationship-focused HIV counseling and testing |
|
31 |
|
|
Condition: |
|
HIV Infections |
Intervention: |
|
Biological: MVA-CMDR vaccine |
|
32 |
|
|
Conditions: |
|
HIV Seropositivity; HIV Infection |
Intervention: |
|
Drug: (Ampligen) polyI-polyC12U |
|
33 |
|
|
Conditions: |
|
Acquired Immune Deficiency Syndrome; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted; HIV Infections |
Intervention: |
|
|
|
34 |
|
|
Condition: |
|
HIV Infections |
Intervention: |
|
|
|
35 |
|
|
Conditions: |
|
Latent Tuberculosis Infection; HIV Infections; Tuberculosis |
Intervention: |
|
|
|
36 |
|
|
Condition: |
|
HIV Infections |
Intervention: |
|
|
|
37 |
|
|
Condition: |
|
Acquired Immunodeficiency Syndrome |
Interventions: |
|
Drug: zidovudine+lamivudine+lopinavir/ritonavir; Drug: zidovudine + lamivudine + efavirenz |
|
38 |
|
|
Condition: |
|
HIV Infection |
Intervention: |
|
Behavioral: strengths-based case managed proactive service model |
|
39 |
|
|
Condition: |
|
HIV Infection |
Intervention: |
|
Biological: ADMVA |
|
40 |
|
|
Conditions: |
|
Acquired Immunodeficiency Syndrome; Lipodystrophy |
Intervention: |
|
|
|
41 |
|
|
Condition: |
|
HIV Infections |
Interventions: |
|
Drug: Lopinavir/Ritonavir; Drug: Emtricitabine; Drug: Stavudine |
|
42 |
|
|
Condition: |
|
HIV |
Intervention: |
|
Drug: Atorvastatin |
|
43 |
|
|
Conditions: |
|
HIV Infections; Herpesvirus 2, Human |
Interventions: |
|
Drug: Acyclovir; Drug: Acyclovir placebo |
|
44 |
|
|
Condition: |
|
HIV Infections |
Intervention: |
|
Drug: Highly active antiretroviral therapy (HAART) |
|
45 |
|
|
Condition: |
|
Human Immunodeficiency Virus (HIV) |
Interventions: |
|
Drug: Truvada (fixed dose combination of tenofovir + emtricitabine) + Stocrin (efavirenz); Drug: Truvada (fixed dose combination of tenofovir + emtricitabine)+ ritonavir/atazanavir (r/ATV); Drug: Truvada (fixed dose combination of tenofovir + emtricitabine) + zidovudine (ZDV) + abacavir (ABC) |
|
46 |
|
|
Condition: |
|
HIV Infections |
Intervention: |
|
Procedure: lumbar puncture, MRI, MRS |
|
47 |
|
|
Condition: |
|
HIV Infections |
Intervention: |
|
Biological: SCBaL/M9 |
|
48 |
|
|
Condition: |
|
HIV Infections |
Interventions: |
|
Biological: HIV-1 immunogen; Biological: HIV-1 Immunogen; Biological: HIV-1 Immunogen |
|
49 |
|
|
Condition: |
|
HIV Infections |
Interventions: |
|
Biological: SAAVI DNA-C2 vaccine; Biological: SAAVI MVA-C vaccine; Biological: Placebo |
|
50 |
|
|
Condition: |
|
HIV Infections |
Intervention: |
|
Drug: Cell Transfer |
|